TY - JOUR
T1 - Characterization of active and infiltrative tumorous subregions from normal tissue in brain gliomas using multiparametric MRI
AU - Fathi Kazerooni, Anahita
AU - Nabil, Mahnaz
AU - Zeinali Zadeh, Mehdi
AU - Firouznia, Kavous
AU - Azmoudeh-Ardalan, Farid
AU - Frangi, Alejandro F.
AU - Davatzikos, Christos
AU - Saligheh Rad, Hamidreza
N1 - Funding Information:
The authors thank Mohammad Peikari, PhD (Department of Medical Biophysics, University of Toronto, Canada) for sharing his code for analysis of histopathological data; Nima Gilani, PhD (Department of Cognitive Neuroscience, Maastricht University) for helping in analysis of IVIM/T2-relaxometry data; and our MRI technician, Behrouz Rafiei, MSc (Imaging Center, Imam Hospital, Tehran University of Medical Sciences, Iran).
Funding Information:
Contract grant sponsor: Tehran University of Medical Sciences & Health Services; contract grant number: 28479; Tehran University of Medical Sciences and Health Services The authors thank Mohammad Peikari, PhD (Department of Medical Biophysics, University of Toronto, Canada) for sharing his code for analysis of histopathological data; Nima Gilani, PhD (Department of Cognitive Neuroscience, Maas-tricht University) for helping in analysis of IVIM/T2-relax-ometry data; and our MRI technician, Behrouz Rafiei, MSc (Imaging Center, Imam Hospital, Tehran University of Medical Sciences, Iran).
Publisher Copyright:
© 2018 International Society for Magnetic Resonance in Medicine
PY - 2018/10
Y1 - 2018/10
N2 - Background: Targeted localized biopsies and treatments for diffuse gliomas rely on accurate identification of tissue subregions, for which current MRI techniques lack specificity. Purpose: To explore the complementary and competitive roles of a variety of conventional and quantitative MRI methods for distinguishing subregions of brain gliomas. Study Type: Prospective. Population: Fifty-one tissue specimens were collected using image-guided localized biopsy surgery from 10 patients with newly diagnosed gliomas. Field Strength/Sequence: Conventional and quantitative MR images consisting of pre- and postcontrast T1w, T2w, T2-FLAIR, T2-relaxometry, DWI, DTI, IVIM, and DSC-MRI were acquired preoperatively at 3T. Assessment: Biopsy specimens were histopathologically attributed to glioma tissue subregion categories of active tumor (AT), infiltrative edema (IE), and normal tissue (NT) subregions. For each tissue sample, a feature vector comprising 15 MRI-based parameters was derived from preoperative images and assessed by a machine learning algorithm to determine the best multiparametric feature combination for characterizing the tissue subregions. Statistical Tests: For discrimination of AT, IE, and NT subregions, a one-way analysis of variance (ANOVA) test and for pairwise tissue subregion differentiation, Tukey honest significant difference, and Games-Howell tests were applied (P < 0.05). Cross-validated feature selection and classification methods were implemented for identification of accurate multiparametric MRI parameter combination. Results: After exclusion of 17 tissue specimens, 34 samples (AT = 6, IE = 20, and NT = 8) were considered for analysis. Highest accuracies and statistically significant differences for discrimination of IE from NT and AT from NT were observed for diffusion-based parameters (AUCs >90%), and the perfusion-derived parameter as the most accurate feature in distinguishing IE from AT. A combination of “CBV, MD, T2_ISO, FLAIR” parameters showed high diagnostic performance for identification of the three subregions (AUC ∼90%). Data Conclusion: Integration of a few quantitative along with conventional MRI parameters may provide a potential multiparametric imaging biomarker for predicting the histopathologically proven glioma tissue subregions. Level of Evidence: 2. Technical Efficacy: Stage 3. J. Magn. Reson. Imaging 2018;48:938–950.
AB - Background: Targeted localized biopsies and treatments for diffuse gliomas rely on accurate identification of tissue subregions, for which current MRI techniques lack specificity. Purpose: To explore the complementary and competitive roles of a variety of conventional and quantitative MRI methods for distinguishing subregions of brain gliomas. Study Type: Prospective. Population: Fifty-one tissue specimens were collected using image-guided localized biopsy surgery from 10 patients with newly diagnosed gliomas. Field Strength/Sequence: Conventional and quantitative MR images consisting of pre- and postcontrast T1w, T2w, T2-FLAIR, T2-relaxometry, DWI, DTI, IVIM, and DSC-MRI were acquired preoperatively at 3T. Assessment: Biopsy specimens were histopathologically attributed to glioma tissue subregion categories of active tumor (AT), infiltrative edema (IE), and normal tissue (NT) subregions. For each tissue sample, a feature vector comprising 15 MRI-based parameters was derived from preoperative images and assessed by a machine learning algorithm to determine the best multiparametric feature combination for characterizing the tissue subregions. Statistical Tests: For discrimination of AT, IE, and NT subregions, a one-way analysis of variance (ANOVA) test and for pairwise tissue subregion differentiation, Tukey honest significant difference, and Games-Howell tests were applied (P < 0.05). Cross-validated feature selection and classification methods were implemented for identification of accurate multiparametric MRI parameter combination. Results: After exclusion of 17 tissue specimens, 34 samples (AT = 6, IE = 20, and NT = 8) were considered for analysis. Highest accuracies and statistically significant differences for discrimination of IE from NT and AT from NT were observed for diffusion-based parameters (AUCs >90%), and the perfusion-derived parameter as the most accurate feature in distinguishing IE from AT. A combination of “CBV, MD, T2_ISO, FLAIR” parameters showed high diagnostic performance for identification of the three subregions (AUC ∼90%). Data Conclusion: Integration of a few quantitative along with conventional MRI parameters may provide a potential multiparametric imaging biomarker for predicting the histopathologically proven glioma tissue subregions. Level of Evidence: 2. Technical Efficacy: Stage 3. J. Magn. Reson. Imaging 2018;48:938–950.
KW - glioma
KW - imaging biomarker
KW - intratumor heterogeneity
KW - machine learning
KW - multiparametric MRI
UR - http://www.scopus.com/inward/record.url?scp=85041670267&partnerID=8YFLogxK
U2 - 10.1002/jmri.25963
DO - 10.1002/jmri.25963
M3 - Article
C2 - 29412496
AN - SCOPUS:85041670267
SN - 1053-1807
VL - 48
SP - 938
EP - 950
JO - Journal of Magnetic Resonance Imaging
JF - Journal of Magnetic Resonance Imaging
IS - 4
ER -